We could not find any results for:
Make sure your spelling is correct or try broadening your search.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and p... CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden. Show more
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
La présentation d'un résumé de dernière minute présentera les résultats du registre SHORE soulignant les avantages d'une surveillance avec HeartCare CareDx, Inc. (Nasdaq : CDNA)- The Transplant...
Neuester Abstract-Vortrag zur Präsentation der Ergebnisse des SHORE-Registers, das die Vorteile einer Überwachung mit HeartCare hervorhebt CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ –...
Late-Breaking Abstract Presentation to Showcase Results from SHORE Registry Highlighting Benefits of Surveillance with HeartCare CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ – a leading...
CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Delivered Total Revenue of $280.3 Million, Exceeding the High End of Updated Guidance for 2023 Grew Testing Services Results for the Second Quarter in a Row CareDx, Inc. (Nasdaq: CDNA) today...
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.46 | -5.74282147316 | 8.01 | 8.7573 | 7.42 | 548555 | 8.02936073 | CS |
4 | -3.05 | -28.7735849057 | 10.6 | 10.71 | 7.42 | 615799 | 8.76246325 | CS |
12 | -1.08 | -12.5144843569 | 8.63 | 12.8337 | 7.42 | 788095 | 9.71785406 | CS |
26 | 2.63 | 53.4552845528 | 4.92 | 12.93 | 4.8 | 1046292 | 9.43960258 | CS |
52 | -0.59 | -7.24815724816 | 8.14 | 12.93 | 4.8 | 940265 | 9.01122075 | CS |
156 | -72.03 | -90.5126916311 | 79.58 | 96.88 | 4.8 | 897562 | 23.44572959 | CS |
260 | -18.75 | -71.2927756654 | 26.3 | 99.83 | 4.8 | 826477 | 28.81336218 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions